Cambrex Corp (NYSE:CBM)

CAPS Rating: 4 out of 5

A life sciences company provides products and services that accelerate and improve the discovery and commercialization of human therapeutics.

Recs

0
Player Avatar kalmia11 (< 20) Submitted: 4/14/2007 11:54:48 PM : Outperform Start Price: $11.64 CBM Score: -34.92

$14/share dividend on May 4

Report this Post Reply

Featured Broker Partners


Advertisement